These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 15459587)

  • 41. Functional diagnosis of coronary stenoses using pressure drop coefficient: a pilot study in humans.
    Kolli KK; Helmy TA; Peelukhana SV; Arif I; Leesar MA; Back LH; Banerjee RK; Effat MA
    Catheter Cardiovasc Interv; 2014 Feb; 83(3):377-85. PubMed ID: 23785016
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Alpha-adrenergic receptor blockade and hyperaemic response in patients with intermediate coronary stenoses.
    Barbato E; Bartunek J; Aarnoudse W; Vanderheyden M; Staelens F; Wijns W; Heyndrickx GR; Pijls NH; De Bruyne B
    Eur Heart J; 2004 Nov; 25(22):2034-9. PubMed ID: 15541840
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adenosine-induced maximal coronary hyperemia for myocardial fractional flow reserve measurements: comparison of administration by femoral venous versus antecubital venous access.
    Lindstaedt M; Bojara W; Holland-Letz T; Yazar A; Fadgyas T; Müller L; Mügge A; Germing A
    Clin Res Cardiol; 2009 Nov; 98(11):717-23. PubMed ID: 19685258
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The reliability of fractional flow reserve measurement in patients with diabetes mellitus.
    Sahinarslan A; Kocaman SA; Olgun H; Kunak T; Kiziltunç E; Ozdemir M; Timurkaynak T
    Coron Artery Dis; 2009 Aug; 20(5):317-21. PubMed ID: 19444091
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Usefulness of coronary fractional flow reserve measurements in guiding clinical decisions in intermediate or equivocal left main coronary stenoses.
    Courtis J; Rodés-Cabau J; Larose E; Potvin JM; Déry JP; Larochellière RD; Côté M; Cousterousse O; Nguyen CM; Proulx G; Rinfret S; Bertrand OF
    Am J Cardiol; 2009 Apr; 103(7):943-9. PubMed ID: 19327420
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Utility and Validity of Intracoronary Administration of Nicorandil Alone for the Measurement of Fractional Flow Reserve in Patients With Intermediate Coronary Stenosis.
    Ishibuchi K; Fujii K; Otsuji S; Takiuchi S; Hasegawa K; Tamaru H; Ishii R; Yasuda S; Nakabayashi S; Yamamoto W; Kusumoto H; Taniguchi Y; Kakishita M; Shimatani Y; Higashino Y
    Circ J; 2019 Sep; 83(10):2010-2016. PubMed ID: 31413232
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hemodynamic response to intravenous adenosine and its effect on fractional flow reserve assessment: results of the Adenosine for the Functional Evaluation of Coronary Stenosis Severity (AFFECTS) study.
    Tarkin JM; Nijjer S; Sen S; Petraco R; Echavarria-Pinto M; Asress KN; Lockie T; Khawaja MZ; Mayet J; Hughes AD; Malik IS; Mikhail GW; Baker CS; Foale RA; Redwood S; Francis DP; Escaned J; Davies JE
    Circ Cardiovasc Interv; 2013 Dec; 6(6):654-61. PubMed ID: 24254709
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relationship between adenosine A2a receptor polymorphism rs5751876 and fractional flow reserve during percutaneous coronary intervention.
    Nardin M; Verdoia M; Negro F; Suryapranata H; Khedi E; De Luca G
    Heart Vessels; 2020 Oct; 35(10):1349-1359. PubMed ID: 32367186
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Optimizing revascularization strategies in patients with multivessel coronary disease: impact of intracoronary pressure measurements.
    Lindstaedt M; Fritz MK; Yazar A; Perrey C; Germing A; Grewe PH; Laczkovics AM; Mügge A; Bojara W
    J Thorac Cardiovasc Surg; 2005 Apr; 129(4):897-903. PubMed ID: 15821661
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Variability of fractional flow reserve according to the methods of hyperemia induction.
    Lim WH; Koo BK; Nam CW; Doh JH; Park JJ; Yang HM; Park KW; Kim HS; Takashima H; Waseda K; Amano T; Kato D; Kurita A; Oi M; Toyofuku M; van Nunen L; Pijls NH
    Catheter Cardiovasc Interv; 2015 May; 85(6):970-6. PubMed ID: 25413590
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of caffeine on fractional flow reserve values measured using intravenous adenosine triphosphate.
    Nakayama M; Chikamori T; Uchiyama T; Kimura Y; Hijikata N; Ito R; Yuhara M; Sato H; Kobori Y; Yamashina A
    Cardiovasc Interv Ther; 2018 Apr; 33(2):116-124. PubMed ID: 28110424
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Determinants of coronary steal in chronic total coronary occlusions donor artery, collateral, and microvascular resistance.
    Werner GS; Fritzenwanger M; Prochnau D; Schwarz G; Ferrari M; Aarnoudse W; Pijls NH; Figulla HR
    J Am Coll Cardiol; 2006 Jul; 48(1):51-8. PubMed ID: 16814648
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of left ventricular unloading by Impella recover LP2.5 on coronary hemodynamics.
    Remmelink M; Sjauw KD; Henriques JP; de Winter RJ; Koch KT; van der Schaaf RJ; Vis MM; Tijssen JG; Piek JJ; Baan J
    Catheter Cardiovasc Interv; 2007 Oct; 70(4):532-7. PubMed ID: 17896398
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy of contrast medium induced Pd/Pa ratio in predicting functional significance of intermediate coronary artery stenosis assessed by fractional flow reserve: insights from the RINASCI study.
    Leone AM; Scalone G; De Maria GL; Tagliaferro F; Gardi A; Clemente F; Basile E; Cialdella P; De Caterina AR; Porto I; Aurigemma C; Burzotta F; Niccoli G; Trani C; Rebuzzi AG; Crea F
    EuroIntervention; 2015 Aug; 11(4):421-7. PubMed ID: 25007836
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Single bolus intravenous regadenoson injection versus central venous infusion of adenosine for maximum coronary hyperaemia in fractional flow reserve measurement.
    van Nunen LX; Lenders GD; Schampaert S; van 't Veer M; Wijnbergen I; Brueren GR; Tonino PA; Pijls NH
    EuroIntervention; 2015 Dec; 11(8):905-13. PubMed ID: 25136887
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intracoronary versus intravenous adenosine-induced maximal coronary hyperemia for fractional flow reserve measurements.
    Khashaba A; Mortada A; Omran A
    Clin Med Insights Cardiol; 2014; 8():17-21. PubMed ID: 24558302
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reactive myocardial hyperaemia for functional assessment of coronary stenosis severity.
    Stoller M; Seiler C
    EuroIntervention; 2017 Jun; 13(2):e201-e209. PubMed ID: 27993753
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of fractional flow reserve measurement on the clinical management of patients with coronary artery disease evaluated with noninvasive stress tests prior to cardiac catheterization.
    Lachance P; Déry JP; Rodés-Cabau J; Potvin JM; Barbeau G; Bertrand OF; Gleeton O; Larose E; Nguyen CM; Noël B; Proulx G; Roy L; De Larochellière R
    Cardiovasc Revasc Med; 2008; 9(4):229-34. PubMed ID: 18928947
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effective radiation dose, time, and contrast medium to measure fractional flow reserve.
    Ntalianis A; Trana C; Muller O; Mangiacapra F; Peace A; De Backer C; De Block L; Wyffels E; Bartunek J; Vanderheyden M; Heyse A; Van Durme F; Van Driessche L; De Jans J; Heyndrickx GR; Wijns W; Barbato E; De Bruyne B
    JACC Cardiovasc Interv; 2010 Aug; 3(8):821-7. PubMed ID: 20723854
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical usefulness of nonhyperemic baseline Pd/Pa as a hybrid baseline Pd/Pa-fractional flow reserve strategy.
    Kwon TG; Matsuzawa Y; Li J; Aoki T; Guddeti RR; Widmer RJ; Cilluffo RR; Lennon RJ; Lerman LO; Lerman A
    Coron Artery Dis; 2015 Jan; 26(1):49-55. PubMed ID: 25279565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.